Understanding Invasive Lobular Breast Cancer for Better Treatment
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
This study is looking at invasive lobular breast cancer to create better models that help us understand how it behaves and responds to treatment, so we can improve care for patients like you who have this specific type of cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11136329 on NIH RePORTER |
What this research studies
This research focuses on invasive lobular breast cancer (ILC), which is a specific type of breast cancer that often behaves differently than the more common types. The team aims to develop and validate models that accurately represent ILC, which will help in understanding its unique characteristics and treatment responses. By collaborating with established cancer research projects, they will analyze various biological and clinical aspects of ILC to improve patient outcomes. This work is crucial as ILC is often overlooked in clinical trials and treatment guidelines.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with invasive lobular breast cancer who are seeking more tailored treatment options.
Not a fit: Patients with other types of breast cancer, such as invasive ductal carcinoma, may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and better management strategies for patients with invasive lobular breast cancer.
How similar studies have performed: While there has been significant research on breast cancer, the specific focus on credentialing models for invasive lobular breast cancer is relatively novel and underexplored.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Oesterreich, Steffi — University of Pittsburgh at Pittsburgh
- Study coordinator: Oesterreich, Steffi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.